# PCOS Immune Function Predicts Metformin Efficacy

> **NCT06325956** · NA · RECRUITING · sponsor: **Shanghai 10th People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Metformin
- Immune Function

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06325956
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-16
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325956, "PCOS Immune Function Predicts Metformin Efficacy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06325956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*